Tag: USA

Home / Established Year

, , , , , , , ,

Eating nuts may help colon cancer survive

According to the CALGB 8903 study published in the Journal of Clinical Oncology, patients with stage III colon cancer who eat at least 2 servings of nuts per week have higher disease-free survival (DFS) and overall survival (OS)...

, , ,

Bariatric surgery can reduce the risk of melanoma

In addition to rapid and lasting weight loss and other health benefits, bariatric surgery is now associated with a 61% reduced risk of malignant melanoma, which is the deadliest skin cancer most closely associated with excessive s..

, , , ,

A new strategy for immunotherapy of multiple myeloma

In recent decades, monoclonal antibody-based cancer treatment has been established as one of the most successful treatment strategies for solid tumors and blood cancers. As the name implies, monoclonal antibodies (mAbs) are antibo..

, , , , , , , , ,

Continuously taking these medicines may double the risk of stomach cancer

A study published in "Intestine" showed that long-term use of proton pump inhibitors will double the risk of gastric cancer . Proton pump inhibitors are a class of drugs used to treat gastric acid reflux. ,Continuous use of thi..

, , , , , ,

Ramucirumab in treatment of gastric cancer

According to statistics, patients with gastric cancer treated in the United States, Europe, and Japan are often recommended to use ramucirumab in combination with other drugs to treat gastric cancer.The US Food and Drug Administra..

, , , , , ,

Roche PD-1 inhibitor liver cancer combination therapy was recognized by the FDA as a breakthrough therapy

The Swiss Roche Group announced yesterday that TECENTRIQ® (atezolizumab) in combination with Avastin® (bevacizumab) has been approved by the US Food and Drug Administration (FDA) for breakthrough therapy for initial (first-line)..

, , , ,

Cabozantinib prolongs progression-free survival for advanced liver cancer

According to a study published in the New England Journal of Medicine published on July 5, Cabozantinib's overall and progression-free survival in patients with advanced hepatocellular carcinoma was significantly better than the p..

, , , , , ,

Benefits of Ramucirumab for patients with high AFP liver cancer

Liver cancerLiver cancer is a typical vascular-rich tumor, and tumor blood vessels play a very important role in the development of liver cancer. Therefore, the current targeted therapy of liver cancer is carried out around anti-a..

, , , ,

New method to detect liver cancer biomarkers

Because liver cancer has many types, strong inheritance, and easy recurrence, identifying biomarkers that can predict disease progression is a key goal in fighting liver cancer.Recently, researchers have developed a method to iden..

, , , , , ,

Proton therapy in liver cancer

Liver cancerIn the past two decades, the number of deaths caused by liver cancer has increased by 80%, becoming one of the fastest growing causes of cancer deaths worldwide.Liver cancer mortality ranks second in the world for canc..

Newer
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy